Hip Surgery in Quiescent or Active Tubercular Hip Arthritis; Is Reactivation Risk Really a Matter
نویسندگان
1 Massachusetts General Hospital, Harvard medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 Community and Preventive Medicine Specialist, Mashhad University of Medical Sciences, Mashhad, Iran
3 Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4 Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
5 Department of Pediatrics, Mashhad University of Medical Sciences, Mashhs, Iran
6 Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
doi
10.22038/abjs.2018.27960.1725چکیده
About 15 % of all musculoskeletal tuberculosis (TB) have hip involvement. Early anti-tubercular drug therapy and other conservative treatment including short-term traction and mobilization programs could prevent hip joint destruction. Reactivation of TB accounts for a significant of active TB incidence, especially in the developed countries with a low TB prevalence. The risk of TB activation for population with the latent form of disease is about 5-10%. According to the existing literature surgery in tubercular hip arthritis would be safe once sufficient debridement and precise anti tubercular chemotherapy has been done.
